(Q85112573)

English

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia

scientific article published on 30 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

S Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

N-G Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B-S Cho

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

K-S Eom

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Y-J Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

H-J Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C-K Min

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S-G Cho

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

D-W Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J-W Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

W-S Min

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C-W Park

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

C-C Kim

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

30 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2110-2119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20882049%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1038/leu.2010.217

0 references

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85112573&oldid=1985397293"